Analyst Consensus
- Current Price
- 79.29 $
- Target (Low)
- 59.00 $
- Target (Mean)
- 94.81 $
- Target (High)
- 131.00 $
- Recommendation
- Buy
- Number of Analysts
- 26
Recommendation Distribution
Recommendation Distribution| Strong Buy | 7 |
|---|
| Buy | 13 |
|---|
| Hold | 5 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 1.4%
- Operating Margin
- 9.4%
- Gross Margin
- 11.1%
- Return on Equity (ROE)
- 4.0%
- Return on Assets (ROA)
- 2.7%
- Revenue Growth
- -0.9%
- Earnings Growth
- -15.8%
- Debt/Equity
- 199.05
- Current Ratio
- 1.15
- Beta
- 1.30
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 11, 2026 | RBC Capital | Outperform → Outperform |
| Jun 1, 2026 | Citigroup | Buy → Buy |
| May 11, 2026 | Wedbush | Outperform → Outperform |
| May 4, 2026 | Evercore ISI Group | Outperform → Outperform |
| Apr 29, 2026 | Mizuho | Outperform → Outperform |
| Apr 29, 2026 | TD Cowen | Buy → Buy |